Laserscope Common Stock and Convertible Debentures - January 2000
Laserscope Inc. engages in the development, manufacture, marketing, and support of medical laser systems and related energy delivery devices for urology, dermatology, and aesthetic surgery markets worldwide. It offers a line of laser systems, which consist of GreenLight PV laser system, a KTP single wavelength laser used for photo-selective vaporization of the prostate procedure.
Taglich Brothers Inc. managed the placement to affiliates of Renaissance Capital Group Inc. after Lasersope announced that it had completed a private placement of subordinate convertible debentures, providing net proceeds to the Company of approximately $2.9 million.
The information contained herein does not constitute a solicitation of any order to buy or sell any securities. The information provided herein may be displayed and printed for your personal, noncommercial use only. You may not reproduce, retransmit, distribute, disseminate, sell, publish, broadcast or circulate the information to anyone, without the express written consent of Taglich Brothers, Inc.